1-20 of 93
Sort by
News

Site of Cancer Could Predict VTE Recurrence After Anticoagulation Cessation

Leah Lawrence
Published: 2023
Abstract
August 2023
View News titled, Site of Cancer Could Predict VTE Recurrence After Anticoagulation Cessation
News

Efgartigimod Shows Long-Term Safety, Efficacy in Long-Standing Primary ITP

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, Efgartigimod Shows Long-Term Safety, Efficacy in Long-Standing Primary ITP
News

Silent Cerebral Infarction During iTTP Can Affect Cognition

Lara C. Pullen, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Silent Cerebral Infarction During iTTP Can Affect Cognition
News

Recombinant ADAMTS13 Yielded Higher ADAMTS13 Exposure Compared With Plasma Exchange for iTTP

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, Recombinant ADAMTS13 Yielded Higher ADAMTS13 Exposure Compared With Plasma Exchange for iTTP
News

COVID-19 Bivalent Boosters Associated With Few Definitive Hematologic AEs

Brandon May
Published: 2023
Abstract
June 2023
View News titled, COVID-19 Bivalent Boosters Associated With Few Definitive Hematologic AEs
News

VTE Linked to Double the Risk for Depression

Leah Lawrence
Published: 2023
Abstract
April 2023
View News titled, VTE Linked to Double the Risk for Depression
News

Consensus Guidelines Outline Treatment of ITP Related to SARS-CoV-2 Infection, Vaccination

Leah Lawrence
Published: 2023
Abstract
March 2023
View News titled, Consensus Guidelines Outline Treatment of ITP Related to SARS-CoV-2 Infection, Vaccination
News

New Strains, Vaccination Bring Lower Risk of VTE From COVID

Thomas R. Collins
Published: 2022
Abstract
January 2023
View News titled, New Strains, Vaccination Bring Lower Risk of VTE From COVID
News

Dalteparin to Apixaban for Upper Extremity DVT in Patients with Cancer

Ruth Jessen Hickman, MD
Published: 2022
Abstract
Mid-January 2023
View News titled, Dalteparin to Apixaban for Upper Extremity DVT in Patients with Cancer
News

Better Recognition Needed for Early Diagnosis of hTTP

Thomas R. Collins
Published: 2022
Abstract
Mid-January 2023
View News titled, Better Recognition Needed for Early Diagnosis of hTTP
News

Racial and Socioeconomic Disparities Persist in US-Based PE Care and Outcomes

Brandon May
Published: 2022
Abstract
Mid-January 2023
View News titled, Racial and Socioeconomic Disparities Persist in US-Based PE Care and Outcomes
News

Diagnosis and Management of Heparin-Induced Thrombocytopenia

Published: 2022
Abstract
December 2022
View News titled, Diagnosis and Management of Heparin-Induced Thrombocytopenia
News

Pulmonary Embolism Response Teams May Change Acute PE Care

Tess Stafford
Published: 2022
Abstract
Mid-November 2022
View News titled, Pulmonary Embolism Response Teams May Change Acute PE Care
News

Long-Term Dabigatran Offers Anticoagulation Alternative in High-Risk Pediatric Thrombophilia

Leah Lawrence
Published: 2022
Abstract
November 2022
View News titled, Long-Term Dabigatran Offers Anticoagulation Alternative in High-Risk Pediatric Thrombophilia
News

rFVIIIFc and rFIXFc Support Perioperative Hemostasis Management in Patients With Hemophilia

Brandon May
Published: 2022
Abstract
November 2022
View News titled, rFVIIIFc and rFIXFc Support Perioperative Hemostasis Management in Patients With Hemophilia
News

Daily Milvexian ≥100 mg Superior to Enoxaparin in Preventing VTE

Jill Sederstrom
Published: 2022
Abstract
March 2022
View News titled, Daily Milvexian ≥100 mg Superior to Enoxaparin in Preventing VTE
News

VTE Events Can Be Attributed to Established Prothrombotic Genotypes

Jill Sederstrom
Published: 2022
Abstract
March 2022
View News titled, VTE Events Can Be Attributed to Established Prothrombotic Genotypes
News

In Heparin-Induced Thrombocytopenia, Is Screening Four Extremities Better Than Screening Two?

Kimberly Retzlaff
Published: 2022
Abstract
March 2022
View News titled, In Heparin-Induced Thrombocytopenia, Is Screening Four Extremities Better Than Screening Two?
News

Secondary Prophylaxis With Full-Dose Anticoagulation Significantly Reduces Recurrent CVC-VTE in Children

Published: 2022
Abstract
February 2022
View News titled, Secondary Prophylaxis With Full-Dose Anticoagulation Significantly Reduces Recurrent CVC-VTE in Children
News

For Anticoagulation in Cancer-Associated Thrombosis, Is Less More?

Published: 2021
View News titled, For Anticoagulation in Cancer-Associated Thrombosis, Is Less More?